Acutaas Chemicals Ltd

NSE: ACUTAAS · BSE: 543349 · Pharmaceuticals & Biotechnology · 38 announcements

Share price: ₹3,154.60
Market cap: ₹25,827 Cr
Revenue (annual): ₹1,339 Cr
Net profit (annual): ₹356.3 Cr
P/E (TTM): 66.9×Sector 47.4×
Promoter holding: 32.66%+0.00% QoQ
FII holding: 21.61%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Capacity Expansion 2 Business Update 2 Annual General Meeting 2 Regulatory Approval 1 Production Started 1 Patent 1 Merger & Restructuring 1 Management Change 1 Dividend 1 Annual Report 1 Acquisition 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

4 Sep 2026 12:04 IST BSE

Capacity ExpansionAlfa Alert

Acutaas Chemicals Capacity Expansion

Acutaas Chemicals Limited inaugurated a new state-of-the-art Pilot Plant at Unit 1 in Sachin, Surat. The facility supports R&D for high potency active pharmaceutical ingredients.

pilot plant: 1.0 plants

Read the filing ↗

22 Aug 2026 17:32 IST BSE

Capacity Expansion

Acutaas Chemicals Capacity Expansion: ₹212 Cr Investment

Acutaas Chemicals approved a Rs. 212 Crore capital expenditure plan for a new manufacturing plant in Gujarat. The Board also announced the upcoming 19th AGM.

Value: ₹212.0 Cr
Execution: By the end of FY 2027-28

Read the filing ↗